Hubei Hongyuan Pharmaceutical Technology Co.,Ltd.’s Net Profit Dropped 63.4% in First Quarter of 2023

Hubei Hongyuan Pharmaceutical Technology Co.,Ltd. (湖北省宏源药业科技股份有限公司) (301246.SZ) reported a net profit of 64.7 million yuan in the first quarter of 2023, down 63.4% year-on-year.

Meanwhile, the company posted 503.9 million yuan in revenue, up 11.7% year-on-year.

At the end of the reporting period, it had 5.9 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 26.4%.